课题基金 / 基金详情

Chromatin regulation by the nuclear receptor PPARbeta/delta

Chromatin regulation by the nuclear receptor PPARbeta/delta
核受体 PPARbeta/delta 调节染色质
批准号:
200640521
负责人:
Professor Dr. Rolf Müller
金额:
$0.0万
依托单位国家:
德国
项目类别:
Research Grants
财政年份:
2011
资助国家:
德国
项目状态:
已结题
起止时间:
2010-12-31 至 2014-12-31

项目摘要

项目成果

Professor Dr. Rolf Müller的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The ligand-regulated nuclear receptor PPARβ/δ can both activate and repress transcription, but the regulation, mechanistic principles and biological consequences of these functions are only partly understood. By using a combination of chromatin immunoprecipitation (ChIP) sequencing and transcriptional profiling we have defined three distinct types of transcriptional responses of target genes to PPARβ/δ ligands or PPARβ/δ depletion. The molecular basis of these distinct target gene responses will be addressed in the proposed project. Our data also suggest that long-range interactions may be an important component of transcriptional regulation by PPARβ/δ. We will analyze the formation and functional implications of DNA looping by genome-wide ChIP-based technologies (ChIA-PET), gene-specific chromosome conformation assays and loss-of-function approaches. Furthermore, we have discovered new interaction partners of PPARβ/δ, including p18HAMLET, a subunit of SRCAP, which can insert histone variant H2A.Z into nucleosomes and thereby plays an essential role in myogenesis through regulation of the myogenin-encoding Myog gene, which we identified as a PPARβ/δ target. We will therefore analyze the influence of PPARβ/δ on genespecific and global organization of H2A.Z and correlate this with transcriptional profiling and the function of PPARβ/δ in myogenic differentiation. Finally, we have identified PIAS2 as an interaction partner of PPARβ/δ, and found that PPARβ/δ is polySUMOylated in a ligand-dependent way. We now plan to study the mechanism of ligand-mediated regulation of SUMOylation and to investigate its functional consequences.
期刊论文(5)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1124/mol.114.094672
发表时间: 2015-02-01
期刊: MOLECULAR PHARMACOLOGY
影响因子: 3.6
作者: [Lieber, Sonja, Scheer, Frithjof, Mueller, Rolf]
通讯作者: Mueller, Rolf
Role of ANGPTL4 in ovarian carcinoma
Lysophosphatidic acid-mediated resistance in ovarian carcinoma
Elucidation of the biosynthesis and the biological function of DKxanthenes during fruiting body formation in Myxococcus xanthus
Transcriptional regulation of the vascular smooth muscle alpha-actin (SMA) gene by the peroxisome-proliferatior activated receptor-beta (PPAR-beta)
国内基金
海外基金
Got2基因对浆细胞样树突状细胞功能的调控及其在系统性红斑狼疮疾病中的作用研究
  • 批准号:
    82371801
  • 项目类别:
    面上项目
  • 资助金额:
    47.00万元
  • 批准年份:
    2023
  • 负责人:
    周海波
  • 依托单位:
精氨酸调控骨髓Tregs稳态在脓毒症骨髓功能障碍中的作用研究
  • 批准号:
    82371770
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2023
  • 负责人:
    宁铂涛
  • 依托单位:
糖尿病ED中成纤维细胞衰老调控内皮细胞线粒体稳态失衡的机制研究
  • 批准号:
    82371634
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2023
  • 负责人:
    赵福军
  • 依托单位:
亚低温调控颅脑创伤急性期神经干细胞Mpc2/Lactate/H3K9lac通路促进神经修复的研究
  • 批准号:
    82371379
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2023
  • 负责人:
    冯军峰
  • 依托单位: